KLOW
KLOW is an 80 mg lyophilised research blend of GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg) in a single vial.
Defined for research.
KLOW is an 80 mg lyophilised research blend of GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg) in a single vial.
Specifications
| Product | KLOW |
|---|---|
| Unit size | 80mg per vial |
| Form | Lyophilised powder |
| Intended use | Laboratory research |
Description
About KLOW
KLOW is a lyophilised research blend that combines four peptides in one vial: GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg). It extends the GLOW formula with KPV, the C-terminal tripeptide of alpha-MSH, which is studied in inflammatory-signalling research, giving laboratories a single-reconstitution format for four-peptide studies.
Key features of KLOW
- Multi-peptide research blend (GHK-Cu, BPC-157, TB-500, KPV)
- Lyophilised solid — stable, easy to store, straightforward to reconstitute
- Unit size: 80 mg / vial (GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, KPV 10 mg)
- Every batch released only after identity, purity, and appearance QC
- Certificate of Analysis (CoA) and batch documentation available on request
KLOW technical specifications
| Product name | KLOW |
| Synonyms | KLOW peptide blend; KLOW stack; GHK-Cu / BPC-157 / TB-500 / KPV blend |
| Class | Multi-peptide research blend (GHK-Cu, BPC-157, TB-500, KPV) |
| GHK-Cu | 50 mg |
| BPC-157 | 10 mg |
| TB-500 | 10 mg |
| KPV | 10 mg |
| Purity | ≥99% (HPLC) |
| Physical form | Lyophilised powder |
| Appearance | Blue to blue-green solid (copper complex) |
| Unit size | 80 mg / vial (GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, KPV 10 mg) |
| Note | Pre-combined in a single vial. Individual component data in the composition rows above. |
Reconstituting and storing KLOW
- Before reconstitution: Store lyophilised vials at 2–8 °C, protected from light and moisture.
- Equilibrate: Allow vial and diluent to reach room temperature before opening.
- Reconstitute: Add Mixing Water (3 ml recommended). Swirl gently — do not vortex.
- After reconstitution: Store at 2–8 °C. Prepare aliquots to minimise freeze–thaw cycles.
- Compatibility: Use only within protocols that comply with your institution’s SOPs and local regulations.
Looking for complementary materials? See GLOW 70mg, KPV 10mg — anti-inflammatory tripeptide research compound, Mixing Water 10 ml.
KLOW in research
Researchers use KLOW in in-vitro and preclinical models examining tissue-repair, collagen and angiogenesis pathways alongside KPV’s role in NF-kB and inflammatory-cytokine signalling. The fixed-ratio blend keeps preparation consistent across experiments. Findings in laboratory systems do not establish safety or efficacy in humans.
Synthesis and quality assurance
Avanti Peptides manufactures each KLOW component via controlled, validated solid-phase peptide synthesis (SPPS) and combines them in fixed ratios to deliver high purity and lot-to-lot consistency. Each batch undergoes identity verification, HPLC purity analysis (≥99%), and appearance inspection before release.
Frequently asked questions about KLOW
What is KLOW?
How should I store the blend?
What diluent should I use for reconstitution?
Do you provide batch documentation / Certificate of Analysis?
Is this product intended for human use?
Legal & safety notice
External resources for researchers
| Product | KLOW |
|---|---|
| Unit size | 80mg per vial |
| Form | Lyophilised powder |
| Intended use | Laboratory research |
Third-party report for this size is pending publication. Contact us for batch details.
Know your batch.
Match your vial's lot number to its documentation.





